Early research (Phase 1)Study completedNCT01288989What this trial is testingAnti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid TumorsWho this might be right forNeoplasms Eli Lilly and Company 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06400160What this trial is testingClinical Trial of TB511 in Advanced Solid TumorsWho this might be right forNSCLCProstate CancerColorectal Cancer+1 more Twinpig Biolab, Inc. 12
Early research (Phase 1)Not Yet RecruitingNCT07341828What this trial is testingC-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard TherapyWho this might be right forMultiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorders (NMOSD)Autoimmune Encephalitis+1 more Huashan Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02629419What this trial is testingCAMB/MAT2203 in Patients With Mucocutaneous CandidiasisWho this might be right forCandidiasis, Chronic Mucocutaneous Matinas BioPharma Nanotechnologies, Inc. 4
Testing effectiveness (Phase 2)Looking for participantsNCT05366218What this trial is testingTafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage LeukemiaWho this might be right forALL, Childhood B-CellAcute Lymphoid Leukemia RelapseAcute Lymphocytic Leukemia Refractory University Hospital Tuebingen 20
Testing effectiveness (Phase 2)Study completedNCT01274182What this trial is testingGP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard TherapyWho this might be right forRheumatoid Arthritis Sandoz 312
Testing effectiveness (Phase 2)Study completedNCT03315039What this trial is testingStudy of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)Who this might be right forLeukemia, Myeloid, Acute Moleculin Biotech, Inc. 7
Early research (Phase 1)Study completedNCT00031031What this trial is testingKanglaite Injection Phase I StudyWho this might be right forSolid Tumors Refractory To Standard TherapyNeoplasms KangLaiTe USA 16
Early research (Phase 1)Looking for participantsNCT06249438What this trial is testingC-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyWho this might be right forSystemic Lupus Erythematosus (SLE)Immune-mediated Necrotizing Myopathy (IMNM)Neuromyelitis Optica Spectrum Disorders (NMOSD)+3 more RenJi Hospital 30
Large-scale testing (Phase 3)Study completedNCT02500043What this trial is testingStudy of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric CancerWho this might be right forRefractory Metastatic Gastric Cancer Taiho Oncology, Inc. 507
Large-scale testing (Phase 3)Study completedNCT02755597What this trial is testingA Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard TherapyWho this might be right forRelapsed/Refractory Multiple Myeloma AbbVie 291
Testing effectiveness (Phase 2)Study completedNCT01253837What this trial is testingL19TNFα in Patients With Advanced Solid TumorsWho this might be right forSolid TumorsColorectal Cancer Philogen S.p.A. 34
Testing effectiveness (Phase 2)UnknownNCT02814864What this trial is testingTrial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard TherapyWho this might be right forPelvic Radiation TherapyRadiation-induced Hemorrhagic Cystitis Assistance Publique - Hôpitaux de Paris 12
Early research (Phase 1)Study completedNCT01820624What this trial is testingLithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+11 more Paolo Caimi, MD 12
Early research (Phase 1)Looking for participantsNCT06883539What this trial is testingA Phase I Study of LXP1788 Injection with Advanced Solid Tumors.Who this might be right forSolid Tumor Malignancies, CancerSolid CancersSolid Tumor Cancer+6 more LaunXP Biomedical Co., Ltd. 24
Testing effectiveness (Phase 2)Ended earlyNCT05576896What this trial is testingHydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer RefractoryWho this might be right forStage IV Colorectal Cancer Positive for BRAF V600E MutationColorectal CancerColorectal Cancer Stage IV Northwestern University 7
Early research (Phase 1)Study completedNCT06296056What this trial is testingPhase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi)Who this might be right forSolid TumorsMetastatic Seoul Hospital 9
Large-scale testing (Phase 3)Active Not RecruitingNCT06230224What this trial is testingA Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin LymphomaWho this might be right forB-Cell Non-Hodgkin Lymphoma (B-NHL) Regeneron Pharmaceuticals 216
Large-scale testing (Phase 3)Looking for participantsNCT07772024What this trial is testingInobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma RefractoryMultiple Myeloma in Relapse CellCentric Ltd. 450
Early research (Phase 1)Study completedNCT01069640What this trial is testingSafety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Shiga University 9